Aurobindo Pharma Ltd News

Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs

In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.

Aurobindo Pharma nears all-time high, up 30% in 4 months; more upside left?

Aurobindo Pharma stock hit a 52-week high at ₹1,585, and quoted close to its record high of ₹1,592 hit in September 2024. HDFC Securities maintains 'Add' rating on the stock.

Stocks to Watch today: HCL Tech, HDFC Bank, Turtlemint, Hexaware Tech, IRFC

Stocks to Watch today, June 29: Tata Motors PV, Torrent Power, Dr Reddy's Laboratories, Aurobindo Pharma, KEC International, and Adani Ports are among the top stocks to watch during today's trade

Stocks to buy: Aurobindo Pharma, Delhivery, Ather Energy, says Ajit Mishra

Market outlook by Ajit Mishra: The analyst from Religare Broking expects Nifty to consolidate in the near-term; among stocks he recommends Delhivery, Ather Energy and Aurobindo Pharma.

Aurobindo Pharma gets US FTC nod for $250 million acquisition of Lannett

Aurobindo Pharma on Monday said its arm Aurobindo Pharma USA, Inc has received approval from the US Federal Trade Commission (FTC) for its USD 250 million acquisition of Lannett Company LLC. The transaction, valued at USD 250 million on a cash-free, debt-free basis and inclusive of normalised working capital, is expected to close before the end of this month, Aurobindo Pharma said in a regulatory filing. Lannett, a Pennsylvania-based generic pharmaceutical company, specialises in the development and commercialisation of a diversified portfolio of complex, non-opioid controlled substances, the filing said. The acquisition will significantly expand Aurobindo USA's product offering in this segment while adding a US-based manufacturing facility to its network, it added. "This acquisition represents a highly compelling strategic and financial opportunity for Aurobindo USA. It accelerates our revenue growth, strengthens our US-based manufacturing capabilities, and enhances our position i

Aurobindo Pharma stock jumps 2% after US FTC approves Lannett acquisition

Aurobindo Pharma received necessary approval from the US Federal Trade Commission (FTC) for the acquisition of the Lannett business.

Stocks to Watch today: Eicher Motors, NTPC, TVS Motor, Groww, Hindalco

Stocks to Watch today, May 25, 2026: Shares of oil marketing companies will remain in focus today after petrol and diesel prices were raised by ₹2.61-2.71 per litre on Monday

Aurobindo Pharma share price plunges 7% as margins weigh on Q4 results

Aurobindo Pharma Q4 results 2026: Aurobindo Pharma has reported a 2 per cent rise in consolidated profit after tax to ₹920.84 crore in the fourth quarter ended March 31.

Stocks to watch today: ITC, Maruti Suzuki, Nykaa, LIC, LG Electronics

Stocks to Watch today, May 22, 2026: Nykaa, LIC, ITC, Honasa Consumer, and Maruti Suzuki are some of the key stocks to watch today

Why pharma stocks are emerging as safe bet amid global market turmoil

The pharma sector is seen as a safe bet because demand remains steady even during inflation or economic slowdowns. Besides, companies earn revenue from multiple global markets, which helps reduce risk

Nandish Shah of HDFC Sec suggests Bear Spread on Nifty; key levels here

Nandish Shah of HDFC Securities has shared a Bear Spread strategy on Nifty, and a Bull Spread strategy on Aurobindo Pharma.

Stock picks: Analyst prefer Aurobindo Pharma, Sona BLW, Tata Steel

Stock picks: Ajit Mishra of Religare Broking recommends buying Aurobindo Pharma, Tata Steel & Sona BLW; here's why

Nifty Midcap Select index hits record high, rallies 13% in one month

The Nifty Midcap Select index hit a new high of 14,223.90, soaring 2% and surpassing its previous high of 14,118 touched on December 1, 2025.

Pharma cos brace for soft Q4; US drag persists; domestic growth cushions

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements

Ex-date alert! Aurobindo Pharma, 3 others to remain in spotlight next week

Notably, Indian equity markets will remain closed on Tuesday, April 14, on account of Dr Baba Saheb Ambedkar Jayanti.

Stocks to Watch today: Rate sensitives, Infosys, Aurobindo Pharma, GAIL

Stocks to Watch today, April 8, 2026: Banks, Real estate, automobiles, Infosys, Aurobindo Pharma are some of the key stocks to watch today

Stocks to Watch today: Godrej Consumer, Aurobindo Pharma, IRFC, PC Jeweller

Stocks to Watch today, April 7, 2025: Godrej Consumer, Aurobindo Pharma, IRFC, ACME Solar Holdings, PC Jeweller, and Titagarh Rail are some of the key stocks to watch today

Aurobindo Pharma sets April 12 as record date for ₹800 crore buyback

Company to repurchase up to 54.24 lakh shares at Rs 1,475 apiece through tender offer route, with promoters also eligible to participate in the buyback

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Astral, Glenmark, Nalco among high conviction F&O bets in April: Systematix

The futures & options market positioning reflects heavy short build-up, creating conditions for sharp but temporary short-covering rallies, says Systematix Institutional Equities.